Showing results (1501-1510 of 1,729) with videos related to

Sort By:
Pageof 173
Journal of Neuropathology and Experimental Neurology|September 18, 2013
Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylationBenjamin Goeppert, Christopher R Schmidt, Lea Geiselhart, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 21, 2016
European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer SurgeryDenis Querleu, François Planchamp, Luis Chiva, et al.
The Journal of Molecular Diagnostics : JMD|October 3, 2022
Homologous Recombination Deficiency as an Ovarian Cancer Biomarker in a Real-World Cohort: Validation of Decentralized Genomic ProfilingCarsten Denkert, Marcel Romey, Brad Swedlund, et al.
Acta Neuropathologica Communications|March 2, 2018
CD74 regulates complexity of tumor cell HLA class II peptidome in brain metastasis and is a positive prognostic marker for patient survivalP S Zeiner, J Zinke, D J Kowalewski, et al.
Lab on a Chip|November 17, 2025
Application of a bioengineered intestinal epithelium for drug permeability and metabolism studiesElisabeth Gill, Stephanie Muenchau Schoepp, Sina Simon, et al.
Plant Communications|June 21, 2026
Cytokinin-activated DIRIGENT13 promotes lignan synthesis to regulate root growth and abiotic stress tolerance by modulating ROS homeostasis in ArabidopsisAlesia Melnikava, François Perreau, Candelas Paniagua, et al.
Oncotarget|October 31, 2015
Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastasesPatrick N Harter, Simon Bernatz, Alexander Scholz, et al.
Acta Neuropathologica|April 9, 2018
Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrenceLeah M Katz, Thomas Hielscher, Benjamin Liechty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 25, 2010
Phase III trial of carboplatin plus paclitaxel with or without gemcitabine in first-line treatment of epithelial ovarian cancerAndreas du Bois, Jørn Herrstedt, Anne-Claire Hardy-Bessard, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 30, 2026
The prognostic significance of TSPO-PET imaging in IDH-mutant glioma: a single-center, retrospective studyKatharina J Müller, Roman Stürzl, Sabrina Kirchleitner, et al.
Pageof 173